Episurf Medical AB will exhibit at FISIC’17 held in London, UK, on September 27-28

Episurf Medical (NASDAQ: EPIS B) will exhibit at FISIC’17 (organised by renowned Fortius Group, UK’s leading private orthopaedic and sports injury group) held in London, UK (Queen Elizabeth II Conference Centre), on September 27-28.

For full program, see https://www.fortiusclinic.com/news-events/fortius-international-sports-injury-conference-2015. For an overview of the industry conferences attended by Episurf Medical, see link. (www.episurf.com/healthcare-professionals/conferences).

For more  information, please contact:

Pål Ryfors, CEO, Episurf Medical

Tel:+46 (0) 709 62 36 69

Email: pal.ryfors@episurf.com

About Episurf Medical

Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and personalized treatment alternatives. Episurf Medical’s Episealer® personalized implants and Epiguide® surgical drill guides are developed for treating localized cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.